Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (Q63844940)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk |
clinical trial |
Statements
FOURIER (English)
0 references
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab (AMG 145) is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease (English)
0 references
8 February 2013
0 references
11 November 2016
0 references
27,564
0 references
40 year
0 references
85 year
0 references